Substance / Medication

Bismuth subcarbonate

Overview

Active Ingredient
bismuth subcarbonate
RxNorm CUI
19475

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Decorating graphdiyne on ultrathin bismuth subcarbonate nanosheets to promote COelectroreduction to formate.
Tang Shang-Feng, Lu Xiu-Li, Zhang Chao et al. · Sci Bull (Beijing) · 2021
PMID: 36654282Other
Copper-Loaded Layered Bismuth Subcarbonate-Efficient Multifunctional Heterogeneous Catalyst for Concerted C-S/C-N Heterocyclization.
Kocsis Marianna, Ötvös Sándor B, Samu Gergely F et al. · ACS Appl Mater Interfaces · 2021
PMID: 34477369OtherFull text (PMC)
Thermal Decomposition of Nanostructured Bismuth Subcarbonate.
Sheng Su, Jin Shengming, Cui Kuixin · Materials (Basel) · 2020
PMID: 32992863OtherFull text (PMC)
Controllable Synthesis of Few-Layer Bismuth Subcarbonate by Electrochemical Exfoliation for Enhanced COReduction Performance.
Zhang Ying, Zhang Xiaolong, Ling Yunzhi et al. · Angew Chem Int Ed Engl · 2018
PMID: 30129234Other
Bismuth Subcarbonate with Designer Defects for Broad-Spectrum Photocatalytic Nitrogen Fixation.
Xu Chenmin, Qiu Pengxiang, Li Liyuan et al. · ACS Appl Mater Interfaces · 2018
PMID: 29969006Other
Leaf-like hybrid of bismuth subcarbonate nanotubes/graphene sheet with highly efficient photocatalytic activities.
Tang Yanping, Yang Chongqing, Li Kan et al. · J Colloid Interface Sci · 2017
PMID: 28049051Other
Renal-Clearable Hollow Bismuth Subcarbonate Nanotubes for Tumor Targeted Computed Tomography Imaging and Chemoradiotherapy.
Hu Xi, Sun Jihong, Li Fangyuan et al. · Nano Lett · 2018
PMID: 29297694Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bismuth subcarbonate (substance)
SNOMED CT
17212003
UMLS CUI
C0053789
RxNorm CUI
19475

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.